Mifepristone pretreatment overcomes resistance of prostate cancer cells to tumor necrosis factor α-related apoptosis-inducing ligand (TRAIL)

Manal A. Eid, Ronald W. Lewis, M. Vijay Kumar

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Mifepristone pretreatment overcomes resistance of prostate cancer cells to tumor necrosis factor α-related apoptosis-inducing ligand (TRAIL)'. Together they form a unique fingerprint.

Medicine & Life Sciences